ModelEdge
Arca Biopharma Inc.
ABIO
Filing type
8-K
Filing date
Apr 29, 2026
Updated
Apr 30, 2026 ยท 3:30 PM

Filing

8-KFinancial Results, Other Events

Exhibits

EX-1.1UNDERWRITING AGREEMENT BY AND AMONG ORUKA THERAPEUTICS, INC. AND LEERINK PARTNERS LLC, TD SECURITIES (USA) LLC, GOLDMAN SACHS & CO. LLC, STIFEL, NICOLAUS & COMPANYEX-5.1OPINION OF DAVIS POLK & WARDWELL LLPEX-99.1Financial Results, Other EventsGRAPHICGraphic